1
UNcovering the Difference Between Ranibizumab and Aflibercept, Focusing on Systemic Anti-vascular Endothelial Growth Factor (VEGF) Effects in Patients With neovascuLar Age-related Macular Degeneration (AMD)
Condition(s):Neovacular Age-related Macular DegenerationLast Updated:May 3, 2017Completed